LIFE SCIENCE  | 
PHYSICAL SCIENCE  | 
RESEARCH TOOLS  | 
SOFTWARE AND COPYRIGHT
TECHNOLOGY COMMERCIALIZATION HOME  | 
SEARCH
Search Results - Research+tools
35
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Disulfide by Design 2.0: A web-based tool for disulfide engineering in proteins
Background:Immunoinformatics employs a computer-driven approach to identifying fragments of the target pathogen that would provide a suitable vaccine, avoiding potential safety concerns from the more traditional approach of using whole pathogens. Immunoinformatics now plays a crucial role in vaccine design, immunodiagnostic development, and antibody...
Published: 4/18/2022
|
Inventor(s):
Alan Dombkowski
,
Douglas Craig
Keywords(s):
Coronavirus
,
COVID-19
Category(s):
Life Science
,
Software
,
Simulation & Modeling
,
Research tools
,
Computer Software
,
Protein/peptides
Microfluidic platforms for live-cell imaging and bio/pathomimetic tissue models
Background:Methodologies to image and quantify tissue models using high-content analysis (HCI) and functional analyses of 3D avatars are needed as such avatars better recapitulate the phenotype of pathobiological processes and better predict efficacy of, and resistance to, a wide variety of therapies. Furthermore, changes in morphometry, viability,...
Published: 2/14/2022
|
Inventor(s):
Bonnie Sloane
,
Kamiar Moin
,
Kyungmin Ji
,
Kingsley Osuala
,
Yong Xu
,
Hongen Tu
Keywords(s):
Category(s):
Specialty compounds
,
Research tools
,
Oncology
,
Microfluidics
,
Life Science
,
Instrumentation
,
Imaging
,
Diseases
,
Devices
,
Cell lines
Polyclonal and Monoclonal Antibodies to TPH1 and TPH2
This technology is a set of antibodies that is used with immunohistochemistry techniques to differentiate between tryptophan hydroxylase 1 and 2, enabling scientists to study how the two enzymes are differentially regulated. Background & Unmet Need: The tryptophan hydroxylase 1 and 2 (TPH1 and TPH2) genes encode enzymes in serotonin biosynthesis....
Published: 11/19/2021
|
Inventor(s):
Donald Kuhn
Keywords(s):
Antibody
,
Assay
,
Immunoassay
Category(s):
Life Science
,
Research tools
,
Biological materials
,
Antibodies
EL4-E2 Cell Line
This technology is a targeted anti-HER2 cell line that can be used as a research tool to develop HER2‑based vaccines for the treatment of aggressive breast cancer. Background & Unmet Need: The human epidermal growth factor 2 (HER2) is overexpressed in approximately 20-30% of all breast cancers and is associated with more aggressive and proliferative...
Published: 3/24/2022
|
Inventor(s):
Wei-Zen Wei
Keywords(s):
Breast Cancer
Category(s):
Cell lines
,
Life Science
,
Research tools
,
Biological materials
Transgenic Mice Carrying Wild Type Human Her-2 Under the Whey Acidic Promoter
This technology is an animal model designed to help pharmaceutical and biotechnology industries develop Her-2 based vaccines or immunotherapeutic agents. Background & Unmet Need: Her-2 positive breast cancer is a breast cancer that is positive for a protein called human epidermal growth factor receptor 2 (Her-2). Presence of Her-2 promotes...
Published: 9/9/2024
|
Inventor(s):
Wei-Zen Wei
,
Ye-Shih Ho
,
Marie Piechocki
Keywords(s):
Animal Model
,
Breast Cancer
,
Research Tool
Category(s):
Animal models
,
Life Science
,
Research tools
Tx2 metal-binding tag for purification and identification of recombinant proteins
Tx2 Metal-Binding Tag for Purification and Identification of Recombinant Proteins WSU Tech#: 11-1058Technology Summary: The technology is a new method of protein purification similar to the principles behind that of a histidine and Ni column system. The new technology uses a different amino acid sequence for generating a metal-binding cluster:T: “H...
Published: 2/28/2022
|
Inventor(s):
Jian-Ping Jin
Keywords(s):
Assay
,
Biotechnology
,
Process
,
Protein
,
Reagents
,
Tool
Category(s):
Life Science
,
Research tools
,
Protein/peptides
A Gene Knockout Mouse Model to Study Lung Disease and a Lung Disease Drug Target
Our researchers have created a gene knockout mouse model that lacks the cytochrome c oxidase subunit IV-2 in order to study the gene’s effects on controlling asthma. Background & Unmeet Need: Asthma is an inflammatory disease of the airways that affects 155 million people of all ages worldwide. Cytochome c oxidase (CcO) is a multi-subunit...
Published: 3/3/2022
|
Inventor(s):
Maik Huettemann
,
Lawrence Grossman
,
David Bassett
Keywords(s):
Asthma
,
Disease
,
Drug Target
,
Gene
,
Knock-out
,
Lung
,
Mouse Model
Category(s):
Animal models
,
Biological materials
,
Life Science
,
Research tools
,
Protein/peptides
An in vivo QQ-systemic protein delivery technology and applications
BackgroundThis invention contains a new composition of our researchers’ previously patented QQ-protein delivery technology and the in vivo applications of this protein delivery technology via systemic administered proteins for cancer diagnosis and therapy. Many proteins and peptides are used as highly specific and effective therapeutic agents....
Published: 11/9/2021
|
Inventor(s):
Jianjun Wang
,
Qianqian Li
,
Quan Jiang
,
Feng Jiang
,
Michael Chopp
Keywords(s):
Cancer Therapies
,
Drug Delivery
Category(s):
Diagnostics
,
Drug Delivery
,
Life Science
,
Oncology
,
Research tools
,
Therapeutics
A protein-induced In situ cell-conversion technology and applications
BackgroundCell reprogramming and trans-differentiation are techniques that convert somatic cells of individuals into either stem cells, including embryonic and adult stem cells (reprogramming) or the other type of somatic cells (trans-differentiation). These techniques are usually performed in the cell culture settings using viral gene delivery and...
Published: 11/9/2021
|
Inventor(s):
Jianjun Wang
,
Qianqian Li
,
Feng Jiang
,
Michael Chopp
,
Guojun Wu
Keywords(s):
Cancer Therapies
,
Drug Delivery
Category(s):
Drug Delivery
,
Life Science
,
Research tools
,
Oncology
Inhibitors of the ubiquitin E3 ligase BCA2 as anti-cancer therapeutic agents
Background:Breast cancer associated protein 2 (BCA2) is a ubiquitin E3 ligase found in invasive breast cancer. Studies have shown that by decreasing its activity, breast cancer cell growth and invasiveness are diminished. Targeting this ligase and inhibiting its activity could play a role in treatment of breast cancer. A molecular approach to inhibiting...
Published: 3/12/2018
|
Inventor(s):
Angelika Burger
,
Andrew Westwell
Keywords(s):
Analog or Analogue
,
Breast Cancer
,
Cancer
,
Disease
,
Drug Target
,
Enzyme
Category(s):
Diseases
,
Oncology
,
Therapeutics
,
Life Science
,
Research tools
1
2
3
4